The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InThe Ontario Ministry of Health has confirmed it will maintain the current long-term care pharmacy funding rate of $1,500 per licensed bed, canceling previously scheduled fee reductions. CareRx Corporation (TSX: CRRX) welcomed the decision, noting that it provides essential financial stability for pharmacy service providers across the province. While the Ministry introduced changes to remove funding for certain unoccupied ward beds, the maintenance of the core fee-per-bed rate removes a significant headwind for the industry. This regulatory clarity is expected to improve earnings visibility for CareRx in its largest market. Analysts view the move as a positive development for the healthcare services sector, as it avoids a potential contraction in revenue streams. The decision ensures that pharmacies can continue delivering specialized care without the immediate threat of planned budgetary cuts.